Analysts have clear opinions on INMD.
There are 3 analysts on the Wall offering 12 month price targets for InMode in the last 3 months. The average price target is $46.00 with a high forecast of $48.00 and a low forecast of $45.00. The average price target represents a 8.59% increase from the last price of $42.36.
InMode Ltd. (INMD) is followed by 3 analysts on the street.
Matthew Taylor from UBS rates it a Hold with a target of $48.00.
Similarly, 2 months ago Jeff Johnson of Robert W. Baird Reiterated a Buy with a target of $45.00.
The consensus on the street is Moderate Buy.
What does InMode Ltd.(INMD) do ?
InMode Ltd. designs, develops, manufactures and markets minimally-invasive aesthetic medical products. It also designs, develops, manufactures and markets non-invasive medical aesthetic products that target a array of procedures including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture and superficial benign vascular and pigmented lesions. The company was founded by Moshe Mizrahy and Michael Kreindel on January 2, 2008 and is headquartered in Yokneam, Israel.
InMode Ltd. (INMD) Insider Trades